Humphrey Jeffrey 4
4 · Magenta Therapeutics, Inc. · Filed May 19, 2022
Insider Transaction Report
Form 4
Humphrey Jeffrey
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2022-05-17+50,000→ 50,000 totalExercise: $1.18Exp: 2032-05-16→ Common Stock (50,000 underlying)
Footnotes (1)
- [F1]This option shall vest and become exercisable in three equal installments, each installment vesting every six months, over the 18 months following the vesting commencement date. The vesting commencement date is May 15, 2022.